Califf lays out drug short­age land­scape, talks post-mar­ket da­ta col­lec­tion for ac­cel­er­at­ed ap­provals

Ef­forts to in­spect gener­ic drug fa­cil­i­ties around the world could end up wors­en­ing US short­ages of sev­er­al key med­i­cines if they lead to halt­ed man­u­fac­tur­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER